FR2865900A1 - Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste - Google Patents
Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste Download PDFInfo
- Publication number
- FR2865900A1 FR2865900A1 FR0401175A FR0401175A FR2865900A1 FR 2865900 A1 FR2865900 A1 FR 2865900A1 FR 0401175 A FR0401175 A FR 0401175A FR 0401175 A FR0401175 A FR 0401175A FR 2865900 A1 FR2865900 A1 FR 2865900A1
- Authority
- FR
- France
- Prior art keywords
- hypoallergenic
- milks
- sweetening
- milk
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000774 hypoallergenic effect Effects 0.000 title claims description 29
- 235000019658 bitter taste Nutrition 0.000 title abstract description 11
- 235000013350 formula milk Nutrition 0.000 title abstract description 5
- 235000008476 powdered milk Nutrition 0.000 title abstract description 4
- 239000008122 artificial sweetener Substances 0.000 title abstract 3
- 235000021311 artificial sweeteners Nutrition 0.000 title abstract 3
- 235000018102 proteins Nutrition 0.000 claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 11
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 11
- 229920002472 Starch Polymers 0.000 claims abstract description 9
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003531 protein hydrolysate Substances 0.000 claims abstract description 9
- 229960005164 acesulfame Drugs 0.000 claims abstract description 8
- 235000001014 amino acid Nutrition 0.000 claims abstract description 7
- 150000001413 amino acids Chemical class 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 7
- 235000019698 starch Nutrition 0.000 claims abstract description 7
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 108010016626 Dipeptides Proteins 0.000 claims abstract description 5
- 239000005018 casein Substances 0.000 claims abstract description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000021240 caseins Nutrition 0.000 claims abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 5
- 229930003231 vitamin Natural products 0.000 claims abstract description 5
- 235000013343 vitamin Nutrition 0.000 claims abstract description 5
- 239000011782 vitamin Substances 0.000 claims abstract description 5
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims abstract description 4
- 239000004377 Alitame Substances 0.000 claims abstract description 4
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 claims abstract description 4
- 235000019409 alitame Nutrition 0.000 claims abstract description 4
- 108010009985 alitame Proteins 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- 150000002016 disaccharides Chemical class 0.000 claims abstract description 3
- 229920001184 polypeptide Polymers 0.000 claims abstract description 3
- 239000003921 oil Substances 0.000 claims abstract 2
- 235000013336 milk Nutrition 0.000 claims description 48
- 210000004080 milk Anatomy 0.000 claims description 48
- 239000008267 milk Substances 0.000 claims description 21
- 235000003599 food sweetener Nutrition 0.000 claims description 19
- 239000003765 sweetening agent Substances 0.000 claims description 19
- 239000000796 flavoring agent Substances 0.000 claims description 10
- 235000019634 flavors Nutrition 0.000 claims description 10
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 235000020122 reconstituted milk Nutrition 0.000 claims description 3
- 239000006172 buffering agent Substances 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 235000020215 hypoallergenic milk formula Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 14
- 108010011485 Aspartame Proteins 0.000 description 12
- 239000000605 aspartame Substances 0.000 description 12
- 235000010357 aspartame Nutrition 0.000 description 12
- 229960003438 aspartame Drugs 0.000 description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 235000019605 sweet taste sensations Nutrition 0.000 description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 229960000367 inositol Drugs 0.000 description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 229960003080 taurine Drugs 0.000 description 4
- 235000010436 thaumatin Nutrition 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 239000005905 Hydrolysed protein Substances 0.000 description 3
- 102000004407 Lactalbumin Human genes 0.000 description 3
- 108090000942 Lactalbumin Proteins 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- -1 soluble or insoluble Proteins 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 235000019160 vitamin B3 Nutrition 0.000 description 3
- 239000011708 vitamin B3 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 239000001329 FEMA 3811 Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000005569 Iron sulphate Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 2
- 235000010434 neohesperidine DC Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000892 thaumatin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical class O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001183 FEMA 4495 Substances 0.000 description 1
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000234676 Marantaceae Species 0.000 description 1
- 241000218164 Menispermaceae Species 0.000 description 1
- 101710084933 Miraculin Proteins 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- CWBZAESOUBENAP-QVNVHUMTSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@H](CO)[C@@H](O)[C@@H]1O CWBZAESOUBENAP-QVNVHUMTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical group CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241000234568 Thaumatococcus Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000008207 calcium folinate Nutrition 0.000 description 1
- 239000011687 calcium folinate Substances 0.000 description 1
- UKLJMHXGZUJRTL-UHFFFAOYSA-L calcium;n-cyclohexylsulfamate Chemical compound [Ca+2].[O-]S(=O)(=O)NC1CCCCC1.[O-]S(=O)(=O)NC1CCCCC1 UKLJMHXGZUJRTL-UHFFFAOYSA-L 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pediatric Medicine (AREA)
- Seasonings (AREA)
- Dairy Products (AREA)
Abstract
Description
2865900 Composition lactée à goût amélioré 2865900 Milky composition with improved taste
La présente invention se rapporte aux nécessités de la vie et plus particulièrement au domaine de l'alimentation. The present invention relates to the necessities of life and more particularly to the field of food.
L'invention a plus particulièrement pour objet de nouveaux laits, facilement ingérables en raison d'une saveur agréable, destinés à l'alimentation des nourrissons ou des très jeunes enfants en bas âge, ayant de 1 à 5 ans. The invention more particularly relates to new milks, easily ingested because of a pleasant flavor, for the feeding of infants or very young children, from 1 to 5 years.
Un problème se pose en effet, à l'heure actuelle, pour l'alimentation des nourrissons et des très jeunes enfants qui ne supportent pas les laits du premier âge, du fait qu'ils sont intolérants au lait ou qu'ils sont allergiques aux protéines du lait. Il faut, dans ce cas, leur administrer des boissons contenant des hydrolysats de protéines, principalement des protéines de lait de vache.. There is currently a problem in feeding infants and toddlers who do not support infant formula because they are intolerant to milk or are allergic to milk. milk protein. In this case, they must be given drinks containing protein hydrolysates, mainly cow's milk proteins.
C'est ainsi qu'on utilise à l'heure actuelle des laits infantiles hypoallergéniques, caractérisés en ce qu'ils contiennent une phase protidique, soluble ou non soluble, rendue hypoallergénique ou hypoantigénique par hydrolyse enzymatique ou par un traitement thermique ou autre. Les protéines hypoallergéniques résultent de l'action d'enzymes hydrolysants sur les protéines du lait et d'un enrichissement éventuel en acides aminés. Ces laits sont dépourvus de polypeptides de poids moléculaire élevé, compris entre 10 000 et 65 000 daltons. Ces laits sont également dépourvus de protéines de sérum (lactoglobuline et lactalbumine) à l'état intact.. Thus, hypoallergenic infant milks are currently used, characterized in that they contain a protein phase, soluble or insoluble, made hypoallergenic or hypoantigenic by enzymatic hydrolysis or by heat treatment or other. Hypoallergenic proteins result from the action of hydrolysing enzymes on milk proteins and possible enrichment in amino acids. These milks are free of high molecular weight polypeptides between 10,000 and 65,000 daltons. These milks are also devoid of serum proteins (lactoglobulin and lactalbumin) in the intact state.
Malheureusement, ces hydrolysats de protéines et sur-tout les hydrolysats de caséine manifestent une saveur franchement désagréable, et notamment présentent une saveur très amère. Unfortunately, these protein hydrolysates and especially casein hydrolysates show a frankly unpleasant taste, and in particular have a very bitter taste.
Les laits hypoallergéniques nécessitent, pour les besoins de la croissance des très jeunes enfants, une teneur minima en protéines, solubles ou insolubles, ou en peptides, ou en acides aminés, pour fournir un apport énergétique et nutritionnel suffisant sur le plan quantitatif et qualitatif. Hypoallergenic milks require, for the growth needs of very young children, a minimum content of proteins, soluble or insoluble, or peptides, or amino acids, to provide a sufficient energy and nutritional intake in terms of quantity and quality.
Or, le problème du goût de ces laits hypoallergéniques est un problème très important car les nourrissons ou les jeunes en- fants ont tendance à rejeter un tel lait ou refusent de boire leur biberon en raison de cette saveur très amère. However, the problem of the taste of these hypoallergenic milks is a very important problem because infants or young children tend to reject such milk or refuse to drink their bottle because of this very bitter taste.
Le formulateur a de ce fait été amené à masquer cette amertume par des glucides, et notamment par des glucides, tels que des amidons ou autres. Cette solution est imparfaite, et n'a pas permis une alimentation plus satisfaisante des nourrissons ou des très jeunes enfants sans que ceux-ci soient amenés à rejeter le contenu de leur biberon. Cependant, le problème du goût n'a pas été résolu. The formulator has thus been led to mask this bitterness by carbohydrates, and especially by carbohydrates, such as starches or others. This solution is imperfect, and has not allowed a more satisfactory feeding of infants or very young children without them having to reject the contents of their bottle. However, the problem of taste has not been solved.
La Demanderesse a constaté que ce problème d'amertume pouvait être résolu d'une manière plus simple et plus efficace, tout en évitant d'apporter en contrepartie des glucides en quanti-tés excessives (maltodextrines, lactose, amidons, amidons hydrolysés). En effet, l'apport important de ces glucides exerce une influence négative sur la valeur nutritionnelle et crée de l'accoutumance au goût sucré. The Applicant has found that this problem of bitterness can be solved in a simpler and more efficient way, while avoiding in return to supply carbohydrates in excessive amounts (maltodextrins, lactose, starches, hydrolysed starches). Indeed, the important contribution of these carbohydrates has a negative influence on the nutritional value and creates addiction to the sweet taste.
Il s'agissait donc de résoudre le problème en réalisant un lait hypoallergénique avec des protéines hydrolysées, qui ne présente-rait pas une saveur amère, et que le nourrisson ne risquerait pas de rejeter en raison de la saveur amère qui apparaîtrait lors de l'ingestion, rapidement ou après quelques minute. La solution proposée par le lait suivant l'invention se caractérise par un lait dont l'amertume est masquée. Il importait également que les laits selon l'invention ne constituent pas un apport calorique excessif.. It was therefore a matter of solving the problem by producing a hypoallergenic milk with hydrolysed proteins, which would not present a bitter taste, and which the infant would not risk rejecting because of the bitter taste that would appear during the treatment. swallowed, quickly or after a few minutes. The solution proposed by the milk according to the invention is characterized by a milk whose bitterness is masked. It was also important that the milks according to the invention do not constitute an excessive calorie intake.
Selon l'invention, le problème ainsi existant a été résolu en produisant des laits hypoallergéniques avec protéines hydrolysées, de composition déterminée, de valeur calorique et nutritionnelle satisfaisante, tout en étant riches en hydrolysats de protéines qui apportent les peptides et acides aminés nécessaires à la nutrition. According to the invention, the problem thus existing has been solved by producing hypoallergenic milks with hydrolysed proteins, of determined composition, of satisfactory caloric and nutritional value, while being rich in hydrolysates of proteins which provide the peptides and amino acids necessary for the production. nutrition.
Ce problème a trouvé sa solution en introduisant dans le lait à base de protéines hydrolysées une quantité d'agent(s) édulcorant(s), masquant l'amertume, à des doses très faibles, de préférence à des doses qui ne sont pas encore trop édulcorantes, mais qui suffisent cependant pour faire disparaître pratiquement complètement la saveur amère gênante présentée par les laits de l'art antérieur. This problem has been solved by introducing into the milk based on hydrolysed proteins a quantity of sweetening agent (s), masking the bitterness, at very low doses, preferably at doses which are not yet too sweet, but sufficient, however, to virtually disappear the annoying bitter flavor presented by the milks of the prior art.
L'invention consiste donc à additionner les laits hypoallergéniques à base d'hydrolysats de protéines d'au moins un agent édulcorant de synthèse, à des doses infra-édulcorantes ou édulcorantes, et en particulier, en ajoutant des quantités très faibles d'un édulcorant de nature dipeptidique, comme il en existe déjà dans l'hydrolysat de protéine et de même nature.. The invention therefore consists in adding the hypoallergenic milks based on protein hydrolysates of at least one synthetic sweetening agent, at infra-sweetening or sweetening doses, and in particular by adding very small amounts of a sweetener. of dipeptide nature, as it already exists in the protein hydrolyzate and of the same nature.
Parmi les édulcorants utilisés, on peut citer: l'acésulfame, l'aspartame, l'acide cyclamique, la glycyrrhizine, la miraculine, la néohéspéridine dihydrochalcone, - le cyclohexyl sulfamate, - le stévioside et encore la thaumatine. Among the sweeteners used, mention may be made of: acesulfame, aspartame, cyclamic acid, glycyrrhizine, miraculin, neohesperidin dihydrochalcone, cyclohexyl sulfamate, stevioside and thaumatin.
Un facteur de sélection parmi ces différents agents réside dans l'absence de toxicité et l'absence d'arrière-goût. Un autre facteur de choix réside dans l'absence de persistance d'une saveur exagérément sucrée. Ceci a conduit à éliminer la monelline extraite des baies de Dioscoreum cumminsii (Menispermacés), appelées encore Serependity Berry (ou baies de la bonne surprise ) dont le pouvoir sucrant est phénoménal mais dont la persistance du signal sucré est finalement un inconvénient souvent reproché à des édulcorants non-glucidiques (20 à 30 minutes). A selection factor among these different agents is the absence of toxicity and the lack of after-taste. Another factor of choice is the lack of persistence of an excessively sweet taste. This has led to the elimination of the monellin extracted from the berries of Dioscoreum cumminsii (Menispermaceae), also called Serependity Berry (or berries of the good surprise) whose sweetening power is phenomenal but whose persistence of the sweet signal is finally a drawback often criticized for non-carbohydrate sweeteners (20 to 30 minutes).
Il convient également que l'agent édulcorant additionné soit stable à la chaleur et ne soit pas susceptible de se dégrader dans un lait trop chaud à l'intérieur du biberon. It is also appropriate that the added sweetening agent is heat stable and is not likely to degrade in milk too hot inside the bottle.
Il est cependant possible, lorsqu'on utilise des agents édulcorants dont le pouvoir sucrant est très élevé, d'associer un tel agent à d'autres édulcorants à effet rapide mais fugace, tels que le saccharose, le fructose, le xylitol et même la saccharine. C'est le cas, en particulier, de la thaumatine, principe édulcorant extrait du fruit de Thaumatococcus danielli (Marantacées). Ce sont des fruits rouges vo-lumineux, de forme triadique, qui contiennent trois gros noyaux entou- rés d'une gelée mucilagineuse, dont la saveur est intensément sucrée. La saveur sucrée est due à la présence de trois protéines séparées et identifiées par électrophorèse. Ce sont les thaumatines 0, I et II. Le pouvoir sucrant des thaumatines est phénoménal. Il est d'environ 1400 fois celui du saccharose. Le goût sucré est cependant persistant et il est associé à une perception retardée. Afin de pallier cette réminiscence, on l'associe à du saccharose ou à du fructose. Ces composés possèdent un faible pouvoir calorique. However, it is possible, when using sweetening agents whose sweetening power is very high, to associate such an agent with other fast-acting but fugitive sweeteners, such as sucrose, fructose, xylitol and even saccharin. This is particularly the case with thaumatin, a sweetening principle extracted from the fruit of Thaumatococcus danielli (Marantaceae). They are triadic-shaped, bright red fruits, which contain three large nuclei surrounded by a mucilaginous jelly, whose flavor is intensely sweet. The sweet taste is due to the presence of three separate proteins identified by electrophoresis. These are thaumatines 0, I and II. The sweetening power of thaumatines is phenomenal. It is about 1400 times that of sucrose. The sweet taste is however persistent and is associated with a delayed perception. To overcome this reminiscence, it is associated with sucrose or fructose. These compounds have a low calorific value.
Parmi les édulcorants de synthèse organique, on citera également les dérivés hémi-synthétiques de certaines flavones naturel-les, comme la naringine contenue dans le mésocarpe de pamplemousse. Trois dihydrochalcones sont plus particulièrement dignes d'intérêt: la néohespéridine dihydrochalcone (NHDC), la naringine dihydrochalcone et 1'hespéritine dihydrochalcone. Among the sweeteners of organic synthesis, mention may also be made of hemi-synthetic derivatives of certain natural flavones, such as the naringine contained in the grapefruit mesocarp. Three dihydrochalcones are particularly noteworthy: neohesperidin dihydrochalcone (NHDC), naringin dihydrochalcone and hesperitin dihydrochalcone.
Curieusement, la saveur sucrée de la NHDC s'accompagne d'une autre saveur de nature mentholée. On peut signaler également la périllartine, qui est la L-syn-oxime de l'aldéhyde perillique, constituant principal de Perilla fruitescens (Labiées) ou qui est synthétisée à partir du Limonène. Curiously, the sweet taste of the NHDC is accompanied by another flavor of mentholated nature. Also noteworthy is perillartine, which is the L-syn-oxime of the perillic aldehyde, the main constituent of Perilla fruitescens (Labiés) or which is synthesized from Limonene.
Cependant, la préférence est accordée aux édulcorants non calorigènes de nature azotée, comme le typtophane, la DL-alanine, le dérivé 6trifluorotryptophane qui possède un pouvoir sucrant très fort qui est environ 2 000 fois celui du saccharose. On accorde surtout la préférence aux édulcorants de nature peptidique, comme l'aspartame (ester méthylique de la N-a-L aspartyl L-phénylalanine). Son pouvoir sucrant est limité (180 à 200 fois supérieur à celui du saccharose). On peut citer encore un analogue de structure dénommé Alitame (voir DUPARGUE P. Fruits 32 (1977) 117-131) qui est un peptide contenant de la D-alanine. Son pouvoir sucrant est 2 000 fois celui du saccharose. However, preference is given to non-caloric sweeteners of a nitrogenous nature, such as typophane, DL-alanine, the derivative trifluorotryptophan which has a very strong sweetening power which is about 2,000 times that of sucrose. In particular, preference is given to sweeteners of a peptide nature, such as aspartame (methyl ester of N-α-L-aspartyl L-phenylalanine). Its sweetness is limited (180 to 200 times that of sucrose). We can also mention a structural analogue called Alitame (see DUPARGUE P. Fruits 32 (1977) 117-131) which is a peptide containing D-alanine. Its sweetness is 2,000 times that of sucrose.
HLNHLN
0 COOCH3 Il 1 CH-C-NH-CH-CH2 CH2OOOH 0 COOCH3 It 1 CH-C-NH-CH-CH2 CH2OOOH
ASPARTAM CK3ASPARTAM CK3
H N CH3H N CH3
ALITAMEalitame
Il faut également signaler l'emploi, selon l'invention, de l'acide cyclamique, de ses sels et de ses dérivés comme le cyclohexyl sulfamate de sodium ou le cyclohexyl sulfamate de calcium. L'acésulfame, qui est le principal concurrent de l'aspartame, possède un pouvoir sucrant équivalent et sa saveur sucrée est exempte d'arrière-goût amer. Le sel de potassium de l'acésulfame est beaucoup plus stable à la chaleur et aux milieux acides. Il trouve, de ce fait, un emploi privilégié dans les laits selon l'invention. It should also be noted the use, according to the invention, of cyclamic acid, its salts and derivatives such as sodium cyclohexyl sulfamate or calcium cyclohexyl sulfamate. Acesulfame, which is the main competitor of aspartame, has an equivalent sweetening power and its sweet flavor is free of bitter aftertaste. The potassium salt of acesulfame is much more stable to heat and acidic environments. It finds, therefore, a preferred use in the milks according to the invention.
D'autres analogues de l'acésulfame alkylés à l'azote décrits par Van der Heidjen (Chemical Senses 10 (1985) 57-72 et 73-88 possèdent un pouvoir édulcorant très supérieur à celui du saccharose. Other nitrogen-alkylated acesulfame analogs described by Van der Heijen (Chemical Senses 10 (1985) 57-72 and 73-88 have a sweetening potency much higher than that of sucrose.
Ils trouvent, de ce fait, une utilisation comparable dans les laits selon l'invention. They find, therefore, a comparable use in the milks according to the invention.
En particulier, on sait que l'aspartame, qui possède un pouvoir édulcorant très intense, est un ester d'acide N-aspartylglutamique. On peut remplacer, dans la molécule d'aspartame, la fraction N-aspartyl par tout autre acide aminé ayant une fonction acide libre sans modifier ses propriétés édulcorantes. In particular, it is known that aspartame, which has a very strong sweetening power, is an N-aspartylglutamic acid ester. In the aspartame molecule, the N-aspartyl fraction can be replaced by any other amino acid having a free acid function without modifying its sweetening properties.
Tous ces composés peuvent être ajoutés aux laits hypoallergéniques, soit isolément, soit en mélange, comme par exemple un mélange d'acesulfame et d'aspartame. All these compounds can be added to hypoallergenic milks, either alone or as a mixture, such as for example a mixture of acesulfame and aspartame.
Les quantités d'agent édulcorant à ajouter aux laits hypoallergéniques sont très faibles et peuvent s'échelonner de 0,001 à 5 mg pour 100 g de préparation lactée exprimée en poids, soit de 2 à 4 mg pour 100 g de lait reconstitué. A cette concentration, la saveur su-crée de l'édulcorant ne se fait pas sentir. L'effet de suppression de la saveur amère est par contre déjà très net et les laits possèdent une saveur nettement plus agréable. The amounts of sweetening agent to be added to the hypoallergenic milks are very low and can range from 0.001 to 5 mg per 100 g of milk formula expressed by weight, ie from 2 to 4 mg per 100 g of reconstituted milk. At this concentration, the su-create flavor of the sweetener is not felt. The effect of suppressing the bitter taste is, however, already very clear and milks have a distinctly more pleasant flavor.
De cette façon, les nourrissons alimentés avec ces laits hypoallergéniques -ainsi que les mères de famille- ont à leur disposition un aliment riche en calories, nécessaire à leur croissance, mais qui pré- sente une saveur dépourvue d'amertume, qui améliore leur palatabilité. In this way, infants fed with these hypoallergenic milks - as well as mothers - have at their disposal a high-calorie food, which is necessary for their growth, but which has a bitterness-free flavor that improves their palatability. .
De préférence, la quantité d'agent édulcorant, et principalement un édulcorant de nature dipeptidique comme l'acide aspartyl glutamique, est de l'ordre de 15 à 30 mg pour 100 g de lait en poudre, soit de 2 à 4 mg pour 100 ml de lait reconstitué. Un dosage préféré sera de 20 mg d'aspartame pour 100 g de lait en poudre, soit 2,6 mg d'aspartame pour 100 ml de produit reconstitué. Preferably, the amount of sweetening agent, and mainly a dipeptide sweetener such as aspartyl glutamic acid, is in the range of 15 to 30 mg per 100 g of powdered milk, ie 2 to 4 mg per 100 mg. ml of reconstituted milk. A preferred dosage will be 20 mg of aspartame per 100 g of milk powder, or 2.6 mg of aspartame per 100 ml of reconstituted product.
Par ailleurs, le lait hypoallergénique selon l'invention peut contenir des protéines solubles, des hydrolysats de protéine, des glucides solubles comme les malto dextrines, des huiles végétales hydrogénées, des amidons, des amidons partiellement hydrolysés ou partiellement oxydés, des disaccharides digestibles ou non digestibles, comme le lactose, le palatinose, des sels minéraux, des agents tampons comme le citrate de sodium, des acides aminés comme la taurine, la méthionine, la cystéine des facteurs de croissance comme l'inositol, l'inositohexaphosphate de calcium et/ou de magnésium, des vitamines, comme la vitamine A ou ses précurseurs (alcool ou aldéhyde caroténoïque), la vitamine E, la vitamine C, les vitamines du groupe B (Vitamines B1, B2, B6, la vitamine PP, l'acide folique, l'acide folinique, la biotine, la vitamine B12), des vitamines D (vitamine D 1, Vitamine D2, vitamine D3), du panthothénate de calcium et des analogues de structure. Furthermore, the hypoallergenic milk according to the invention may contain soluble proteins, protein hydrolysates, soluble carbohydrates such as malto dextrins, hydrogenated vegetable oils, starches, partially hydrolysed or partially oxidized starches, digestible or non-digestible disaccharides. digests, such as lactose, palatinose, mineral salts, buffering agents such as sodium citrate, amino acids such as taurine, methionine, cysteine, growth factors such as inositol, calcium inosithexaphosphate and / or or magnesium, vitamins, such as vitamin A or its precursors (alcohol or aldehyde carotenoic), vitamin E, vitamin C, vitamins of group B (Vitamins B1, B2, B6, vitamin PP, folic acid , folinic acid, biotin, vitamin B12), vitamin D (vitamin D 1, vitamin D 2, vitamin D 3), calcium panthothenate and structural analogues.
Des exemples de lait hypoallergénique ainsi traité sont fournis ci-après: EXEMPLE I: Lait hypoallergénique à l'Aspartame Protéines solubles (hydrolysats de caséine) 12,500 g Hydrolysats de lactalbumine 4,500 g Dextrine maltose 12,700 g Huiles végétales hydrogénées 24,000 g Amidon de blé 13,900 g Lactose 18,400 g Citrate de Sodium 0,050 g Chlorure de Calcium 0,030 g Chlorure de magnésium 0,030 g Chlorhydrate de choline 0, 044 g Taurine 0,040 g Méthionine 0,020 g Sulfates de fer 0,014 g Sulfate de Zinc 0,070 g Sulfate de cuivre 0,010 g Inositol 0,040 g Vitamine A 0, 050 g Vitamine E 0,05 g Vitamine C 0,40 g Vitamine B2 0,005 g Carnitine 2, 5 g Pantothenate de Calcium 0,75 g Vitamine B1 0,010 g Vitamine B6 0,015 g Vitamine PP 0,25 g Vitamine D 1 0,0015 g Acide folique 0,25 g Vitamine K 0,005 g Biotine 0,45 g Vitamine B12 0,175 g Aspartame 0,020 g Pour 100g de lait en poudre EXEMPLE II: Lait hypoallergénique à l'acésulfame Taurine 0,040 g Méthionine 0,020 g Sulfate de fer 0,014 g Sulfate de Zinc 0,070 g Sulfate de Cuivre 0,010 g Inositol 0,040 g Vitamine A 0,050 g Vitamine E 0,050 g Vitamine C 0,60 g Vitamine B2 0,15 g Carnitine 2,5 g Pantothenate de Calcium 1,25 g Vitamine B I 0,010 g Vitamine B6 0,40 g Vitamine PP 0,60 g Vitamine D 0,0005 g Folinate de Calcium 0,10 g Vitamine K 0,005 g Biotine 0,60 g Vitamine B12 0,350 g Acésulfame 0,015 g Autolysat de peptone 16,00 g Amidon hydrolysé 46,00 g Graisse animales hydrogénées 18,00 g Lactose 7,00 g Inositohexaphosphate de Calcium et de Ma- 0,500 g gnésium Chlorhydrate de Choline 0,05 g Pour 100 g de lait en poudre EXEMPLE III lait hypoallergénique à l'aspartame et au cyclamate Hydrolysat de Caséine 9,75 g Hydrolysat de peptones 8,75 g Hydrolysat de Lactalbumine 16,70 g Matières grasses végétales hydrogénées 29,00 g Amidon de blé 10,45 g Lactose 31,OOg Taurine 1g Méthionine 2,5 g Glycine 2,5 g Inositol 0,75 g Choline (Chie de) 1,50 g Levure de bière 0, 45 g Aspartame 0,015 g Cyclohexylsulfamate de sodium 0,0075 g Pour 100 g de lait en poudre La reconstitution du lait s'effectue, en règle générale, en dispersant 10 à 15 g de lait en poudre dans 100 ml de liquide aqueux, comme de l'eau minérale. Examples of hypoallergenic milk thus treated are provided below: EXAMPLE I Hypoallergenic Milk with Aspartame Soluble Proteins (Casein Hydrolysates) 12,500 g Lactalbumin Hydrolysates 4,500 g Maltose Dextrin 12,700 g Hydrogenated Vegetable Oils 24,000 g Wheat Starch 13,900 g Lactose 18.400 g Sodium citrate 0.050 g Calcium chloride 0.030 g Magnesium chloride 0.030 g Choline hydrochloride 0.04 g Taurine 0.040 g Methionine 0.020 g Iron sulphate 0.014 g Zinc sulphate 0.070 g Copper sulphate 0.010 g Inositol 0.040 g Vitamin At 0, 050 g Vitamin E 0.05 g Vitamin C 0.40 g Vitamin B2 0.005 g Carnitine 2.5 g Calcium pantothenate 0.75 g Vitamin B1 0.010 g Vitamin B6 0.015 g Vitamin PP 0.25 g Vitamin D 1 0.0015 g Folic acid 0.25 g Vitamin K 0.005 g Biotin 0.45 g Vitamin B12 0.175 g Aspartame 0.020 g For 100 g of milk powder EXAMPLE II: Hypoallergenic milk with acesulfame Taurine 0.040 g Methionine 0.020 g Iron sulphate 0.014 g Zinc sulphate 0.070 g Copper sulphate 0.010 g Inositol 0.040 g Vitamin A 0.050 g Vitamin E 0.050 g Vitamin C 0.60 g Vitamin B2 0.15 g Carnitine 2.5 g Calcium pantothenate 1.25 g Vitamin BI 0.010 g Vitamin B6 0.40 g Vitamin PP 0.60 g Vitamin D 0.0005 g Calcium folinate 0.10 g Vitamin K 0.005 g Biotin 0.60 g Vitamin B12 0.350 g Acesulfame 0.015 g Peptone autolysate 16.00 g Starch hydrolysed 46.00 g Hydrogenated animal fat 18.00 g Lactose 7.00 g Calcium and Ma-Inosithexaphosphate 0.500 g Gnesium Choline Hydrochloride 0.05 g For 100 g of milk powder EXAMPLE III hypoallergenic milk with aspartame and with cyclamate Casein hydrolyzate 9.75 g Peptone hydrolyzate 8.75 g Lactalbumin hydrolyzate 16.70 g Hydrogenated vegetable fats 29.00 g Wheat starch 10.45 g Lactose 31, OOg Taurine 1g Methionine 2.5 g Glycine 2.5 g Inositol 0.75 g Choline (Chie of) 1.50 g Brewer's yeast 0, 45 g Aspartame 0.015 g Cyclohexylsul Sodium famate 0,0075 g For 100 g of milk powder The reconstitution of milk is usually carried out by dispersing 10 to 15 g of powdered milk in 100 ml of aqueous liquid, such as mineral water.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0401175A FR2865900A1 (en) | 2004-02-06 | 2004-02-06 | Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0401175A FR2865900A1 (en) | 2004-02-06 | 2004-02-06 | Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2865900A1 true FR2865900A1 (en) | 2005-08-12 |
Family
ID=34778576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0401175A Pending FR2865900A1 (en) | 2004-02-06 | 2004-02-06 | Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2865900A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007118610A1 (en) * | 2006-04-12 | 2007-10-25 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Sports beverages containing carbohydrates |
CN103859041A (en) * | 2014-03-20 | 2014-06-18 | 深圳市味奇生物科技有限公司 | Powder fortified with calcium applicable to the nutritional supplement of babies and preparation method of powder |
WO2017186299A1 (en) * | 2016-04-28 | 2017-11-02 | Symrise Ag | Use of 3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1497531A (en) * | 1966-06-16 | 1967-10-13 | Mini Ind Alimenta | Diet milk for infants |
DE3440734A1 (en) * | 1984-11-08 | 1986-05-07 | Hoechst Ag, 6230 Frankfurt | Milk-like beverages |
WO1991009538A1 (en) * | 1989-12-22 | 1991-07-11 | Novo Nordisk A/S | Nutritionally complete enteral diet product |
EP0665012A1 (en) * | 1994-01-31 | 1995-08-02 | Snow Brand Milk Products Co., Ltd. | Antiallergy agent and nutritional composition containing glutamine and process for the production thereof |
JPH07264992A (en) * | 1994-03-31 | 1995-10-17 | Snow Brand Milk Prod Co Ltd | Peptide-containing composition and production thereof |
US6194009B1 (en) * | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
EP1210880A1 (en) * | 1998-10-28 | 2002-06-05 | San-Ei Gen F.F.I., Inc. | Compositions containing sucralose and application thereof |
EP1224869A1 (en) * | 2001-01-12 | 2002-07-24 | Campina Melkunie B.V. | Method for producing a gluten-free peptide preparation and preparation thus obtained |
EP1281321A1 (en) * | 2000-05-09 | 2003-02-05 | Kabushiki Kaisha Yakult Honsha | Stable acidic milk drinks, process for producing the same and additive for acidic milk drinks to be used therein |
-
2004
- 2004-02-06 FR FR0401175A patent/FR2865900A1/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1497531A (en) * | 1966-06-16 | 1967-10-13 | Mini Ind Alimenta | Diet milk for infants |
DE3440734A1 (en) * | 1984-11-08 | 1986-05-07 | Hoechst Ag, 6230 Frankfurt | Milk-like beverages |
WO1991009538A1 (en) * | 1989-12-22 | 1991-07-11 | Novo Nordisk A/S | Nutritionally complete enteral diet product |
EP0665012A1 (en) * | 1994-01-31 | 1995-08-02 | Snow Brand Milk Products Co., Ltd. | Antiallergy agent and nutritional composition containing glutamine and process for the production thereof |
JPH07264992A (en) * | 1994-03-31 | 1995-10-17 | Snow Brand Milk Prod Co Ltd | Peptide-containing composition and production thereof |
US6194009B1 (en) * | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
EP1210880A1 (en) * | 1998-10-28 | 2002-06-05 | San-Ei Gen F.F.I., Inc. | Compositions containing sucralose and application thereof |
EP1281321A1 (en) * | 2000-05-09 | 2003-02-05 | Kabushiki Kaisha Yakult Honsha | Stable acidic milk drinks, process for producing the same and additive for acidic milk drinks to be used therein |
EP1224869A1 (en) * | 2001-01-12 | 2002-07-24 | Campina Melkunie B.V. | Method for producing a gluten-free peptide preparation and preparation thus obtained |
Non-Patent Citations (2)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 02 29 February 1996 (1996-02-29) * |
PLEBANI A ET AL: "Monoclonal and polyclonal antibodies against casein components of cow milk for evaluation of residual antigenic activity in 'hypoallergenic' infant formulas", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 27, no. 8, 1997, pages 949 - 956, XP002294957, ISSN: 0954-7894 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007118610A1 (en) * | 2006-04-12 | 2007-10-25 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Sports beverages containing carbohydrates |
JP2009533032A (en) * | 2006-04-12 | 2009-09-17 | スズカー アクチエンゲセルシャフト マンハイム/オシュセンフルク | Carbohydrate-containing sports drink |
EA016561B1 (en) * | 2006-04-12 | 2012-05-30 | Зюдцукер Акциенгезелльшафт Маннхайм/Окзенфурт | Carbohydrate-containing functional beverages based on protein hydrolysate containing isomaltulose and/or leukrose |
CN103859041A (en) * | 2014-03-20 | 2014-06-18 | 深圳市味奇生物科技有限公司 | Powder fortified with calcium applicable to the nutritional supplement of babies and preparation method of powder |
WO2017186299A1 (en) * | 2016-04-28 | 2017-11-02 | Symrise Ag | Use of 3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one |
CN108697133A (en) * | 2016-04-28 | 2018-10-23 | 西姆莱斯有限公司 | The purposes of 3- (3- hydroxyls -4- methoxyl groups-phenyl) -1- (2,4,6- trihydroxies-phenyl) propyl- 1- ketone |
US10702484B2 (en) | 2016-04-28 | 2020-07-07 | Symrise Ag | Use of 3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-phenyl) propan-1-one |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3539970B2 (en) | Flavoring composition and flavoring method | |
EP1535520B1 (en) | Infant formula containing prebiotic additive | |
US6613367B1 (en) | Infant formula | |
CA2170242C (en) | Novel dietetic phospholipid compositions and use thereof as a dietary supplement | |
RU2396879C2 (en) | Infant formula containing sialic acid and its manufacturing method | |
EP1112693A1 (en) | Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption | |
RU2507863C2 (en) | Method for reduction of bitterness and improvement of taste of hydrolysed children alimentation mixture free of protein | |
JP2006510711A (en) | Method for stimulating in vivo production of a protein with a composition comprising leucine | |
TW200738171A (en) | High-potency sweetener composition with vitamin and compositions sweetened therewith | |
JP5657222B2 (en) | Vitamin C enhanced beverage | |
EP0463154A1 (en) | Polypeptide and amino acid based composition | |
EP0117047B1 (en) | Improved fruit flavored beverages | |
JP2008148568A (en) | Protein supplemental food | |
FR2865900A1 (en) | Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste | |
WO2021016665A1 (en) | A gummy composition | |
JP2945995B2 (en) | Oligopeptide mixture, production thereof and nutrition feeding composition for patient of heptic disease | |
WO2013062015A1 (en) | Sweet composition showing reduced bitterness of sweetener having bitter taste, method for reducing bitterness, and food, drink, drug or quasi drug having reduced bitterness | |
JPH03151838A (en) | Production of solubilized royal jelly and royal jelly drink | |
JP3111237B2 (en) | Composition for patients with liver disease | |
JP2008113603A (en) | Method for masking unfavorable smell and taste of supplement beverage | |
JPS5948975B2 (en) | Improving the taste of artificial sweeteners | |
JPH04126051A (en) | Nutritional preparation for patient suffering from phenylketonuria | |
JPS58180429A (en) | Prepared nutritious substance for homocystinuric infant | |
WO2007143088A2 (en) | Protein ingredient with improved sensory quality and nutritionals with improved flavor containing same | |
WO2011068149A1 (en) | Cholecystokinin secretion enhancer |